2009, Clinical Trials and Conditions - Medical Cannabis Brief

Former member of the National Advisory Council on Drug Abuse (NACDA) and National Institute on Drug Abuse (NIDA) Joins Ehave, Inc; Ehave Appoints Psychopharmacologist, Board-Certified Psychiatrist, And Licensed Physician, Bankole Johnson To Its Medical Advisory Board

Cannabis Law Report

JULY 6, 2021

He was also listed in “Best Doctors in America” in 2007, 2009, and 2010. We look forward to Dr. Johnson’s expertise as we expand our mental health analytical platform and enter clinical trials.” In 2019, Dr. Johnson received the R. ” About Ehave, Inc. Ehave, Inc.

Research and Development

Research and Development Wellness and Beauty Clinical Trials Therapy

5 Things Veterans Deserve to Know About Medical Marijuana

CannaMD

NOVEMBER 8, 2019

A 2009 Canadian clinical trial of synthetic cannabinoid medication, nabilone , found: The majority of patients (72%) receiving nabilone experienced either cessation of nightmares or a significant reduction in nightmare intensity. Medical marijuana may also play a role in treating nightmares.

Marijuana

Marijuana Treatment Research and Development Patients

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

The Cannigma

DECEMBER 12, 2022

And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. It became illegal in the US in 2009.

History

History Microdosing Research and Development Clinical Trials

Here’s what you need to know about cannabis research

The Cannigma

JULY 1, 2022

The highest quality form of scientific research, in terms of whether the results provide predictive power (which is what science is all about), is the placebo controlled, double blind, randomized clinical trial. Non-clinical research can help answer questions regarding safety and risk in very powerful ways.

Research and Development

Research and Development Data THC Clinical Trials

A Hidden Origin Story of the CBD Craze

SMPL

MAY 26, 2020

And at last, in February 2009 a dual peak on a testing graph appeared, indicating the presence of CBD. “I By the summer of 2009, the lab had identified five strains with significant CBD and THC. In the fall of 2010, a Project CBD website was set up where anyone could look through studies organized by disease or condition.

CBD

CBD Research and Development Pharmaceutical Seed-To-Sale

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. 2009 July ; 205(1): 171–174.

Extraction

Extraction Pharmaceutical CBD Epilepsy

First ethics at MAPS in question and now Australia’s Mind Medicine look to have some serious integrity issues too

Cannabis Law Report

JULY 25, 2022

Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. The charity was eventually instructed to pull an advertisement for the study by the ethics committee that conditionally approved the trial.

Medicine

Medicine Therapy Research and Development Business

Medical Marijuana Offers Hope for Treatment of PTSD

FloridaMarijuana.net

AUGUST 15, 2018

A January 2018 Scientific American article titled “As Vets Demand Cannabis for PTSD, Science Races to Unlock Its Secrets” details a 2009 clinical trial in Canada which showed that the nighttime administration of THC reduced the frequency and intensity of nightmares in 72 percent of the 47 patients studied.”.

Treatment

Treatment Marijuana Research and Development Therapy

New Frontiers in the Law of Psychedelics

Cannabis Law Report

JULY 9, 2021

Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , Clinical Trial ID NCT03866174, available at [link].

Law

Law Therapy Clinical Trials Research and Development

Meredith Fisher-Corn, MD…….”Are You Able to Answer Your Patients’ Medical Marijuana Questions”

TheAnswerPage

JANUARY 11, 2022

For example, most, if not all, states have legalized the use of medical marijuana to treat specific health conditions for which there is no or only poor quality clinical evidence of efficacy and safety. Since 2009, Dr. Fisher-Corn has served as Editor-in-Chief of TheAnswerPage.com.

Patients

Patients Education Marijuana Therapy

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. Spasticity from neurological conditions. Background. Conclusions. Bonini et al.

Research and Development

Research and Development Medicine Access Media

Best strains and terpenes for migraine relief

The Cannigma

JANUARY 13, 2023

Migraines are a peculiarly painful condition. Scientists still don’t understand exactly why migraines happen, nor how to cure the condition – but perhaps cannabis can help. A primary headache, such as a migraine, is its own condition, and not caused by a separate condition.

Terpenes

Terpenes Strains THC Treatment

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety

Safety CBD Clinical Trials Oil

EU Licensed European Pharmaceutical Company, Freia Farmaceutici Srl

Cannabis Law Report

JULY 23, 2019

Freia (www.freiafarmaceutici.it) was founded in 2009 and is presently the only company in Italy and one of few in Europe, to have created and are marketing hemp based pharmaceutical products approved by the Italian Ministry of Health and licensed for sale throughout the EU. LGC has also appointed two members to Freia’s board of directors.

Pharmaceutical

Pharmaceutical Seed-To-Sale Compliance Compliance

Incense: “Religious Viagra to TRPV3 Activator”

TheAnswerPage

OCTOBER 27, 2021

Although drugs are available for both conditions not all patients are well treated and novel drugs in both conditions are badly needed. Boswellia resin: from religious ceremonies to medical uses: a review of in vitro, in vivo and clinical trials. 61, 1281-1293 (2009). 22, 3024-3034 (2008). Moussaieff, R.

Clinical Trials

Clinical Trials Sativa Conditions Medicine

Article: Canada: Future Care Costs For Cannabis In Personal Injury Claims

Cannabis Law Report

JUNE 11, 2019

The accident also reactivated a pre-existing psychological condition which manifested as a chronic pain syndrome, and a pre-existing depressive disorder which was in partial remission at the time of trial. The subsequent accident, in 2009, caused soft tissue injuries to Kirby’s neck, right shoulder and upper back.

Chronic Pain

Chronic Pain Cannabis History Treatment

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Originally a lawyer, Yang began working in startups and early stage growth companies as a founder or executive from 2000 to 2009.

Research and Development

Research and Development Medicine Treatment Pharmaceutical

Medical Cannabis Brief

Former member of the National Advisory Council on Drug Abuse (NACDA) and National Institute on Drug Abuse (NIDA) Joins Ehave, Inc; Ehave Appoints Psychopharmacologist, Board-Certified Psychiatrist, And Licensed Physician, Bankole Johnson To Its Medical Advisory Board

5 Things Veterans Deserve to Know About Medical Marijuana

Trending Sources

The history and science of psychedelics: from acid and shrooms to ketamine and salvia

Here’s what you need to know about cannabis research

A Hidden Origin Story of the CBD Craze

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

First ethics at MAPS in question and now Australia’s Mind Medicine look to have some serious integrity issues too

Medical Marijuana Offers Hope for Treatment of PTSD

New Frontiers in the Law of Psychedelics

Meredith Fisher-Corn, MD…….”Are You Able to Answer Your Patients’ Medical Marijuana Questions”

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Best strains and terpenes for migraine relief

ElleVet Sciences Publishes Safety Study On CBD For Animals

EU Licensed European Pharmaceutical Company, Freia Farmaceutici Srl

Incense: “Religious Viagra to TRPV3 Activator”

Article: Canada: Future Care Costs For Cannabis In Personal Injury Claims

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Stay Connected